Exact Sciences Shares Are Trading Higher After the Company Shared New Modeling Data on the Projected Impact of Its Cologuard Test Since Its FDA Approval
精密科学的股票正在交易中,该公司分享了新的建模数据,预测其Cologuard测试自FDA批准以来的影响
Exact Sciences Shares Are Trading Higher After the Company Shared New Modeling Data on the Projected Impact of Its Cologuard Test Since Its FDA Approval
精密科学的股票正在交易中,该公司分享了新的建模数据,预测其Cologuard测试自FDA批准以来的影响
使用浏览器的分享功能,分享给你的好友吧